全文获取类型
收费全文 | 1119篇 |
免费 | 64篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 23篇 |
妇产科学 | 8篇 |
基础医学 | 194篇 |
口腔科学 | 7篇 |
临床医学 | 88篇 |
内科学 | 161篇 |
皮肤病学 | 38篇 |
神经病学 | 34篇 |
特种医学 | 71篇 |
外科学 | 172篇 |
综合类 | 4篇 |
预防医学 | 41篇 |
眼科学 | 16篇 |
药学 | 107篇 |
肿瘤学 | 162篇 |
出版年
2022年 | 10篇 |
2021年 | 13篇 |
2020年 | 6篇 |
2019年 | 18篇 |
2018年 | 19篇 |
2017年 | 16篇 |
2016年 | 19篇 |
2015年 | 17篇 |
2014年 | 22篇 |
2013年 | 24篇 |
2012年 | 45篇 |
2011年 | 45篇 |
2010年 | 29篇 |
2009年 | 25篇 |
2008年 | 40篇 |
2007年 | 56篇 |
2006年 | 69篇 |
2005年 | 56篇 |
2004年 | 34篇 |
2003年 | 46篇 |
2002年 | 35篇 |
2001年 | 40篇 |
2000年 | 51篇 |
1999年 | 44篇 |
1998年 | 15篇 |
1997年 | 12篇 |
1996年 | 12篇 |
1995年 | 7篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 50篇 |
1991年 | 32篇 |
1990年 | 28篇 |
1989年 | 28篇 |
1988年 | 30篇 |
1987年 | 22篇 |
1986年 | 22篇 |
1985年 | 20篇 |
1984年 | 15篇 |
1983年 | 18篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1975年 | 6篇 |
1974年 | 6篇 |
1973年 | 4篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1967年 | 3篇 |
排序方式: 共有1189条查询结果,搜索用时 8 毫秒
1.
2.
3.
M Asakawa S Wada N Hayahara R Yayumoto T Kishimoto M Maekawa Y Morikawa J Kawakita M Umeda A Horii 《Hinyokika kiyo. Acta urologica Japonica》1990,36(11):1361-1369
Estramustine phosphate disodium (Estracyt) was used in the treatment of 38 patients with prostatic carcinoma for at least 1 year. Of these patients 37 patients were treated with Estracyt as primary treatment and 1 patient had been treated with another antiandrogenic therapy before the Estracyt treatment. Estracyt was given orally in a dose of 560 mg/day in divided oral doses. The clinical evaluation was done for the change of PAP, the relapse rate, the survival rate and the side effect. Among 22 cases which had shown abnormally high PAP values before the treatment started, the values decreased or normalized in 21 cases (95.5%) in the first year of administration of Estracyt. In 6 cases, however, the values increased again in the second year or later. Relapse was observed in 10 (26.3%) out of 38 cases. Relapse rate was 2.6%, 51.7%, and 51.7%, at the first, third, and fifth year, respectively. Survival rate was 97.4% at the first year, 88.5% at the third year, and 68.8% at the fifth year for the follow-up study. Side effects were observed in 14 (36.8%) out of 38 cases. The main side effect was gynecomastia. Gastro-intestinal disturbance and edema were also observed. However, there were only 2 cases (5.2%) in which administration of Estracyt had to be discontinued. 相似文献
4.
Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer 总被引:8,自引:0,他引:8
下载免费PDF全文
![点击此处可从《The American journal of pathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Furukawa T Sunamura M Motoi F Matsuno S Horii A 《The American journal of pathology》2003,162(6):1807-1815
We previously found frequent loss of heterozygosity at 12q21 and 12q22-q23.1 in primary pancreatic cancers, and the DUSP6/MKP-3 gene residing in this region at 12q22 lost its expression in the great majority of pancreatic cancer cell lines. The DUSP6/MKP-3 protein is a dual-specificity phosphatase that dephosphorylates the active form of ERK, making a feedback loop to control ERK activity. Gain-of-function mutations of KRAS2 occur in the great majority of pancreatic cancer cells, and loss of expression of DUSP6/MKP-3 may synergistically promote constitutive activation of ERK and uncontrolled cell growth. To study loss of the feedback pathway and its impact on pancreatic cancer cell growth, we first investigated the expression of DUSP6/MKP-3 in primary pancreatic cancer tissues immunohistochemically; we found up-regulation in mildly as well as severely dysplastic/in situ carcinoma cells and down-regulation in invasive carcinoma, especially in the poorly differentiated type. Adenovirus-mediated reintroduction of DUSP6/MKP-3 into cultured pancreatic cancer cells induced strong expression of recombinant DUSP6/MKP-3 and reduction of phosphorylated ERK in a dose-dependent manner based on the multiplicity of infection and resulted in suppression of cell growth. Moreover, analyses by flow cytometry and immunocytochemistry revealed that the exogenous expression of DUSP6/MKP-3 induced apoptosis. These results show that DUSP6 exerts apparent tumor-suppressive effects in vitro and suggest that DUSP6 is a strong candidate tumor suppressor gene at 12q22 locus. 相似文献
5.
Kazuhiko Orikasa Shin-ichi Fukushige Senji Hoshi Seiichi Orikasa Keiichi Kondo Yasuhide Miyoshi Yoshinobu Kubota A. Horii 《Journal of human genetics》1998,43(4):228-230
Prostate cancer is a major cause of cancer death among elderly men in America, Europe, and Japan. However, the molecular
mechanism of carcinogenesis is not yet well characterized. Frequent loss of heterozygosity (LOH) on chromosome 10q was reported
in prostate cancer, and a candidate tumor suppressor gene, PTEN, was isolated on chromosome band 10q23.3. To investigate the genetic alterations of PTEN, we examined 45 primary prostate cancer specimens. LOH at the PTEN locus was observed in two (11.1%) of 18 tumors. However, no mutations were observed in any of the primary prostate cancers.
These data suggest that mutation of the PTEN gene does not play a major role in prostate carcinogenesis of Japanese patients.
Received: February 6, 1998 / Accepted: July, 3, 1998 相似文献
6.
Toru Furukawa Rumi Fujisaki Yoshitaro Yoshida Naomi Kanai Makoto Sunamura Tadayoshi Abe Kazunori Takeda Seiki Matsuno Akira Horii 《Modern pathology》2005,18(8):1034-1042
DUSP6/MKP-3 is identified as a candidate tumor suppressor gene for pancreatic cancer. The aim of this study was to elucidate the roles of DUSP6 in the pancreatic carcinogenesis through the pancreatic intraepithelial neoplasia and/or intraductal papillary-mucinous neoplasms, both of which are considered to be precursor lesions of invasive carcinoma of the pancreas, by comparing with involvements of other major tumor suppressive pathways. Expressions of DUSP6, CDKN2A, TP53, and SMAD4 were investigated by immunohistochemistry in a total of 206 lesions of dysplastic ductal precursors and carcinomas retrieved from 52 pancreata with invasive ductal carcinomas and 51 of those with intraductal papillary-mucinous neoplasms. The intensity of staining was evaluated in lesions at different atypical grades and statistically compared among them. Mutations of KRAS2 were analyzed by methods of the allele-specific oligonucleotide hybridization and nucleotide sequencing. In pancreata with invasive ductal carcinomas, expressions of DUSP6 were abrogated exclusively in the invasive carcinoma cells in contrast to its fairly preserved expressions in pancreatic intraepithelial neoplasia. In pancreata with intraductal papillary-mucinous neoplasms, abrogated expressions of DUSP6 were observed in a relatively small fraction of intraductal adenoma/borderlines and intraductal carcinomas. Most of the intraductal adenoma/borderline lesions with abrogation of DUSP6 harbored mutations of KRAS2. None of the molecules was associated with each other in any grade of lesions. Morphological variations of papillae of the intraductal papillary-mucinous neoplasms were evaluated and analyzed for their associations with abrogations of the molecules, which resulted in finding of no significant associations. Our results suggest that the abrogation of DUSP6 is associated exclusively with progression from pancreatic intraepithelial neoplasia to the invasive ductal carcinoma while it is potentially associated with initiation of intraductal papillary-mucinous neoplasms with mutated KRAS2, which is independent of other major tumor suppressive pathways in both types of neoplasms. 相似文献
7.
Association of Epstein-Barr virus with oral cancers 总被引:2,自引:0,他引:2
8.
Horii A Smith PF Darlington CL 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》2001,140(2):252-200
Spontaneous recovery from the oculomotor and postural symptoms of unilateral labyrinthectomy (UL) is known as vestibular
compensation, which is a useful model for investigation of the mechanisms of lesion-induced CNS plasticity. In the present
study, to elucidate the molecular biological basis of vestibular compensation, we investigated changes in the mRNA expression
of glutamate receptor subunit/subtypes in the rat central vestibular system, including the vestibular nucleus complex (VNC),
inferior olive (IO), and cerebellar flocculus following UL, using a real-time quantitative polymerase chain reaction (PCR)
method. In normal control animals, regional differences in the expression of several glutamate receptor subunit/subtypes,
e.g., NR1 and NR2A subunits of the N-methyl-D-aspartic acid (NMDA) receptor, GluR2 and KA2 subtypes of non-NMDA receptors, and mGluR1 and mGluR7 metabotropic glutamate
receptors, were consistent with previous results from studies using in situ hybridization histochemistry, suggesting that
the real-time quantitative PCR method was a reliable procedure for evaluation of changes in mRNA expression. In the vestibular
nucleus complex, NR2A, GluR2 and mGluR7 mRNA were ipsilaterally downregulated by 6 h following UL (P<0.05, P<0.05 and P<0.01, respectively). In the inferior olive, no changes in gene expression were observed. In the ipsilateral flocculus, KA2
mRNA expression was increased by 50 h post-UL (P<0.05). However, in the contralateral flocculus, mGluR1 mRNA was downregulated by 6 h post-UL (P<0.005). Both the increase in KA2 mRNA expression in the ipsilateral flocculus and the decrease in mGluR1 mRNA expression
in the contralateral flocculus may have had the effect of reducing Purkinje cell inhibition of ipsilateral VNC neurons, thereby
contributing to the rebalancing of spontaneous resting activity between the ipsilateral and contralateral VNCs. It is suggested
that such changes in the activities of the floccular-VNC pathways may be important to the vestibular compensation process.
Electronic Publication 相似文献
9.
Muramatsu H Horii T Morita M Hashimoto H Kanno T Maekawa M 《International journal of medical microbiology : IJMM》2003,293(2-3):191-197
We evaluated effects of medium composition, including basic amino acid content and pH, on susceptibility to carbapenems such as imipenem, panipenem and meropenem, in clinical isolates of Pseudomonas aeruginosa. Susceptibility to carbapenems was reduced by basic amino acids in the medium, while susceptibilities to ceftazidime and aztreonam were not. Among carbapenems, susceptibility to panipenem was most sharply reduced by addition of basic amino acids to 1:16 Mueller-Hinton agar (MHA). In 174 of 175 clinical isolates, MICs for carbapenems were affected to different degrees by medium composition. One isolate, in which MICs for carbapenems did not differ between MHA and 1:16 MHA, showed reduced production of porin (OprD). Our results suggest that susceptibility to individual carbapenems, especially panipenem, is difficult to evaluate based on MICs for other carbapenems determined on MHA. For a better prediction of antibiotic efficacy, it may be important to evaluate the susceptibility for each carbapenem individually. 相似文献
10.
Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis 总被引:7,自引:0,他引:7
Inoue H Furukawa T Sunamura M Takeda K Matsuno S Horii A 《Genes, chromosomes & cancer》2001,31(3):295-299
Pancreatic ductal carcinoma is one of the malignant diseases with the poorest prognosis. To develop effective methods for better treatment of pancreatic cancer patients, we tried to analyze the course of multistep carcinogenesis of the pancreatic ductal cells. IPMT (intraductal papillary-mucinous tumor) is thought to be one of the premalignant lesions of the pancreas, which would transform into carcinomas. Loss of 18q at the SMAD4 locus is known to be an early genetic change in pancreatic ductal carcinomas. It is not clear, however, whether or not the target gene for inactivation is SMAD4. Using 18 IPMTs, we analyzed LOH at the SMAD4 locus and observed frequent LOH (7/14, 50%). No mutations were observed in any of the tumors. Moreover, the expression level of the SMAD4 protein did not show a reduction in IPMTs. These results suggested that (i) inactivating mutation of the SMAD4 gene is a rather late genetic change in pancreatic carcinogenesis, and (ii) there may be an unknown tumor suppressor gene in 18q, other than SMAD4, that is involved in pancreatic ductal carcinogenesis. 相似文献